Dexmedetomidine

Dexmedetomidine
  • CAS No.:113775-47-6
Other grades of this product :
Dexmedetomidine Basic information
Product Name:Dexmedetomidine
Synonyms:(+)-4-[(S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole;4-[(S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole;DexmedetomidineHclC13H16N2.Hcl;Dexmedetomidine Hcl C13H16N2.Hcl 145108-58-3(Hcl);(S)-4-[1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole;(S)-Medetomidine;5-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole;d-Medetomidine
CAS:113775-47-6
MF:C13H16N2
MW:200.28
EINECS:601-281-8
Product Categories:Aromatics Compounds;Aromatics;Chiral Reagents;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Inhibitors
Mol File:113775-47-6.mol
Dexmedetomidine Chemical Properties
Melting point 146-149°C
Boiling point 381.9±11.0 °C(Predicted)
density 1.053±0.06 g/cm3 (20 ºC 760 Torr)
storage temp. Sealed in dry,Room Temperature
pka13.89±0.10(Predicted)
Safety Information
MSDS Information
Dexmedetomidine Usage And Synthesis
Chemical PropertiesWhite Solid
UsesDexmedetomidine is a sedative drug that has many benefits when given to children under anesthesia, such as improved pain relief and reduced agitation following their surgery. The FDA-approved indications for dexmedetomidine are sedation of intubated and mechanically ventilated patients in the intensive care unit (ICU) and peri-procedural (or peri-operative) sedation of non-intubated patients.
DefinitionChEBI: Dexmedetomidine is a medetomidine. It has a role as an alpha-adrenergic agonist, a non-narcotic analgesic, an analgesic and a sedative. It is an enantiomer of a levomedetomidine.
Brand namePrecedex (Hospira).
Side effectsThis drug is most commonly given to cause sedation, so extreme sedation/lethargy for a short period of time is an expected side effect. Pale gums and lowered heart and respiratory rates can occur. Rarely, vomiting, diarrhea, and collapse may occur. When injected into the muscle, this medication can cause temporary pain at the injection site.
Mode of actionThe mechanism of action of dexmedetomidine is as an Adrenergic alpha2-Agonist. Dexmedetomidine selectively binds to presynaptic alpha-2 adrenoceptors located in the brain, thereby inhibiting the release of norepinephrine from synaptic vesicles. This leads to an inhibition of postsynaptic activation of adrenoceptors, which inhibit sympathetic activity, thereby leading to sedation and anxiolysis. The analgesic effect of this agent is mediated by binding to alpha-2 adrenoceptors in the spinal cord.
Referenceshttps://www.statpearls.com/articlelibrary/viewarticle/20424/ https://pubchem.ncbi.nlm.nih.gov/compound/dexmedetomidinehttps://www.drugs.com/mtm/dexmedetomidine.html Dexmedetomidine: A Review of Its Use for Sedation in the Intensive Care Setting DOI: 10.1007/s40265-015-0419-5
Dexmedetomidine Preparation Products And Raw materials

Welcome!

Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.

  • NO. 18 ,Wujiang Road, Wulidian Street, Jiangbei District, Chongqing
  • +86-23-6139-8061 +86-13650506873
  • danny@chemdad.com sales@chemdad.com
  • www.chemdad.com
  • WhatsApp +86-13650506873

Name

phone

company

email

message

Payment methods
Google translate: 日本语日本语 한국어한국어 FrançaisFrançais DeutschDeutsch EspañaEspaña TürkiyeTürkiye